Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Investors in ADMA Biologics may claim losses after allegations of revenue inflation cause stock drop.
ADMA
$8.86
+$0.18 +2.07%

Investors in ADMA Biologics may claim losses after allegations of revenue inflation cause stock drop.

Market News
18 Apr 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

The Rosen Law Firm is investigating potential securities claims for ADMA Biologics shareholders following allegations that the company inflated revenue through channel stuffing, as reported by a short seller. This news caused ADMA Biologics' stock to drop 16.6% on March 24, 2026. Investors who purchased ADMA securities may be eligible for compensation through a class action lawsuit without upfront fees. The Rosen Law Firm encourages affected investors to contact them to join the case and seek recovery of losses.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News
Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App